Tag: SPRB

Spruce Biosciences announced an EPS of $(1.24) for FY23, marking an improvement from $(1.96) compared to the previous year. Collaboration ...

Spruce Biosciences has reached a major milestone in its CAHmelia-204 clinical trial, surpassing its target enrollment of 90 patients by ...